American Tower heads into the final week of September with its stock down 4.5% on the week and 5% over the past month, a meaningful pullback against a backdrop where the Street's conviction is quietly building rather than fading.
The analyst picture is the most interesting tension here. Despite the price weakness, the direction of travel from the Street has been persistently upward. Barclays, the most recent mover, raised its target to $199 from $198 on September 30 while keeping an Overweight rating. That follows Barclays upgrading the stock outright in August, moving from Equal-Weight to Overweight and lifting the target to $198. Before that, RBC Capital and Wolfe Research both upgraded in late June and early July respectively, and Goldman Sachs assumed coverage with a Buy in June with a $215 target. The consensus mean price target now sits at $215.74, against a current price of $167.35, a gap of roughly 29% that reflects both the Street's genuine optimism and the stock's persistent underperformance of those targets this year.
The lending market offers no clue about what is driving the selling pressure, because there is essentially none. Short interest is a minimal 1.3% of free float, and while it has risen around 8% over the past week in share terms, it remains close to its lowest level of the past month after a 17% decline over the prior 30 days. Borrow is essentially free at 0.37%, and availability is effectively uncapped, with 343 million shares available to lend against a short position of only 6.3 million shares. This is not a stock with aggressive short sellers making a directional call. The ORTEX short score sits at 30, low on its scale, consistent with a name where the bears are making no real stand.
Options positioning is equally calm. The put/call ratio closed at 0.74 on Tuesday, fractionally above its 20-day average of 0.73. The z-score is just 0.39, nowhere near the kind of defensive extreme that would suggest investors are scrambling for downside protection. The 52-week range on the PCR runs from 0.44 to 1.26, so there is plenty of room for sentiment to shift in either direction before the October 26 earnings date.
What the bulls and bears are genuinely disagreeing about is the pace and quality of recovery in the core tower business. The bull case rests on AMT's CoreSite data center platform growing at 18% year on year, leverage now below 5x, and the long-term structural argument around 5G densification and eventual 6G demand. DISH churn has been largely absorbed into guidance, and Europe is seeing over 700 new builds in 2026. The bear case is harder to dismiss in the near term: carrier activity is intentionally subdued in 2026 because new spectrum does not require additional capital spend, US and Canada revenue growth has been compressed by churn, and the stock's 17.2x EV/EBITDA already asks investors to look through a period of slower AFFO-per-share progression. The price-to-book has compressed nearly 1.3 points over the past 30 days to 28.1x, and PE has fallen 1.2 points to 23.9x, both moving in the direction the bears would welcome.
Factor scores add texture to the story. AMT scores in the 77th percentile for EPS surprise and 90-day EPS momentum, and the days-to-cover rank sits in the 81st percentile. Against that, 12-month forward EPS year-on-year improvement ranks only in the 38th percentile, consistent with the bear case of modest near-term AFFO progression. Wikipedia page views produced a retail attention z-score of nearly 2.0 in the week to September 23, suggesting the pullback is drawing more eyeballs to the name.
The most closely correlated peers have had an equally rough week. CCI fell 7.3% and SBAC dropped 7.4%, both outpacing AMT's 4.5% decline, which suggests the sector-wide pressure from rate expectations is doing most of the heavy lifting rather than anything AMT-specific. The more rate-neutral REITs in the peer set, EXR and CUBE, each fell barely 1% to 2% on the week, sharpening the contrast.
With earnings scheduled for October 26, the key variable to watch is management's commentary on 2026 carrier activity guidance and whether the pace of DISH churn normalization allows any upgrade to the net organic tenant billings growth figure that has been weighing on the stock all year.
See the live data behind this article on ORTEX.
Open AMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
